Your browser doesn't support javascript.
loading
A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor.
Hara, Ryujiro; Kawada, Hiroshi; Kikuti, Yara Yukie; Kikkawa, Eri; Harada, Kaito; Aoyama, Yasuyuki; Ogiya, Daisuke; Toyosaki, Masako; Suzuki, Rikio; Machida, Sinichiro; Ohmachi, Ken; Onizuka, Makoto; Ogawa, Yoshiaki; Masuda, Ryota; Iwazaki, Masayuki; Nakamura, Naoya; Ando, Kiyoshi.
Afiliación
  • Hara R; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan. ryujirohara@tokai-u.jp.
  • Kawada H; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Kikuti YY; Department of Pathology, Tokai University School of Medicine, Isehara, Japan.
  • Kikkawa E; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Harada K; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Aoyama Y; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Ogiya D; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Toyosaki M; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Suzuki R; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Machida S; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Ohmachi K; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Onizuka M; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Ogawa Y; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
  • Masuda R; Department of General Thoracic Surgery, Tokai University School of Medicine, Isehara, Japan.
  • Iwazaki M; Department of General Thoracic Surgery, Tokai University School of Medicine, Isehara, Japan.
  • Nakamura N; Department of Pathology, Tokai University School of Medicine, Isehara, Japan.
  • Ando K; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.
Int J Hematol ; 113(4): 606-610, 2021 Apr.
Article en En | MEDLINE | ID: mdl-33389657
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Alelos / Janus Quinasa 2 / Frecuencia de los Genes / Inhibidores de Puntos de Control Inmunológico / Trombocitemia Esencial / Mutación Tipo de estudio: Diagnostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Alelos / Janus Quinasa 2 / Frecuencia de los Genes / Inhibidores de Puntos de Control Inmunológico / Trombocitemia Esencial / Mutación Tipo de estudio: Diagnostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Japón